Recently it has been demonstrated that activated astrocytes in multiple sclerosis lesions show a significant upregulation of complement complex activators, receptors and complement components [1], but as it has also been shown by others before, this complement activation was mainly reflected by increased deposition of early complement components such as C1q or C3 [28, 29]. This evidence concerns the gene C3 and multiple sclerosis.